Evidence map›Paper›PMID 33098551›Full record

ArticleMolecular biology reports2020

Proteome analysis of endometrial tissue from patients with PCOS reveals proteins predicted to impact the disease.

Mehdi Alikhani, Fatemehsadat Amjadi, Mehdi Mirzaei, Yunqi Wu, Faezeh Shekari, Mahnaz Ashrafi, Mehdi Mehdizadeh, Matthew McKay, Sara Taleahmad, Samaneh Aghajanpour and 4 more

Abstract read
PubMed Publisher
In one paragraph

Article in Molecular biology reports, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 8 papers.

0numbers the graph read from it
0cells of the map it votes in
8citing papers in PubMed
0.6field-weighted citation impact, top 32% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

8 citing papers in PubMed, 13 citations in OpenAlex.

  1. Trial
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Review
  8. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

14 authors at 5 institutions in 2 countries.

Mehdi Alikhani *Department of Molecular Systems Biology, Cell Science Research Center, Royan Institute for Stem Cell Biology and Technology, ACECR, Banihashem Sq., Banihashem St., Ressalat highway, P.O. Box: 16635-148, 1665659911, Tehran, Iran.
Fatemehsadat Amjadi *Cellular and Molecular Research Center, Faculty of Advanced Technologies, Department of Anatomical Sciences, Iran University of Medical Sciences, Tehran, Iran.
Mehdi Mirzaei *Department of Molecular Sciences, Macquarie University, Sydney, NSW, 2109, Australia.
Yunqi WuDepartment of Molecular Sciences, Macquarie University, Sydney, NSW, 2109, Australia.
Faezeh ShekariDepartment of Molecular Systems Biology, Cell Science Research Center, Royan Institute for Stem Cell Biology and Technology, ACECR, Banihashem Sq., Banihashem St., Ressalat highway, P.O. Box: 16635-148, 1665659911, Tehran, Iran.
Mahnaz AshrafiObstetrics and Gynecology Department, School of Medicine, Iran University of Medical Science, Tehran, Iran.
Mehdi MehdizadehCellular and Molecular Research Center, Faculty of Advanced Technologies, Department of Anatomical Sciences, Iran University of Medical Sciences, Tehran, Iran.
Matthew McKayDepartment of Molecular Sciences, Macquarie University, Sydney, NSW, 2109, Australia.
Sara TaleahmadDepartment of Molecular Systems Biology, Cell Science Research Center, Royan Institute for Stem Cell Biology and Technology, ACECR, Banihashem Sq., Banihashem St., Ressalat highway, P.O. Box: 16635-148, 1665659911, Tehran, Iran.
Samaneh AghajanpourDepartment of Endocrinology and Female Infertility, Reproductive Biomedicine Research Center, Royan Institute for Reproductive Biomedicine, ACECR, PO Box: 16635-148, Tehran, Iran.
Vivek GuptaDepartment of Clinical Medicine, Macquarie University, Sydney, NSW, Australia.
Hossein BaharvandDepartment of Stem Cells and Developmental Biology, Cell Science Research Center, Royan Institute for Stem Cell Biology and Technology, ACECR, Tehran, Iran.
Reza AflatoonianDepartment of Endocrinology and Female Infertility, Reproductive Biomedicine Research Center, Royan Institute for Reproductive Biomedicine, ACECR, PO Box: 16635-148, Tehran, Iran. R.Aflatoonian@gmail.com.
Ghasem Hosseini SalekdehDepartment of Molecular Systems Biology, Cell Science Research Center, Royan Institute for Stem Cell Biology and Technology, ACECR, Banihashem Sq., Banihashem St., Ressalat highway, P.O. Box: 16635-148, 1665659911, Tehran, Iran. salekdeh@Royaninstitute.org.ORCID http://orcid.org/0000-0002-5124-4721
Royan Institute · IRAGRF Ltd · AUIran University of Medical Sciences · IRMacquarie University · AUUniversity of Science and Culture · IR

Funding

Royan Institute 1234132
6 · The paper itself

Abstract

Polycystic ovary syndrome (PCOS) is a complex disease that causes an ovulatory infertility in approximately 10% of reproductive-age women. We searched for candidate proteins that might contribute to endometrial receptivity defects in PCOS patients, and result in adverse reproductive outcomes. Shotgun proteomics approach was used to investigate the proteome profile of the endometrium at the luteal phase in PCOS patients compared to healthy fertile individuals. Biological process and pathway analyses were conducted to categorize the proteins with differential expressions. Confirmation was performed for a number of proteins via immunoblotting in new samples. 150 proteins with higher abundance, and 46 proteins with lower abundance were identified in the endometrial tissue from PCOS patients compared to healthy fertile individuals. The proteins with higher abundance were enriched in protein degradation, cell cycle, and signaling cascades. Proteins with lower abundance in PCOS patients were enriched in extracellular matrix (ECM) composition and function, as well as the salvage pathway of purine biosynthesis. Metabolism was the most affected biological process with over 100 up-regulated, and approximately 30 down-regulated proteins. Our results indicate significant imbalances in metabolism, proteasome, cell cycle, ECM related proteins, and signaling cascades in endometrial tissue of PCOS, which may contribute to poor reproductive outcomes in these patients. We postulate that the endometria in PCOS patients may not be well-differentiated and synchronized for implantation. Possible roles of the above-mentioned pathways that underlie implantation failure in PCOS will be discussed. Our findings need to be confirmed in larger populations.

Indexed as

EndometriumAdultFemaleHumansLuteal PhasePolycystic Ovary SyndromeProteomeProteomicsYoung AdultProteomeEndometrial tissueLuteal phasePCOSShotgun proteomics

Identifiers

PMID33098551
OpenAlexW3094582372

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.